Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Gri Bio Inc (GRI)
Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 620
  • Shares Outstanding, K 646
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,020 K
  • 60-Month Beta -1.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.20
Trade GRI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -81.47
  • Most Recent Earnings $-3.64 on 11/14/23
  • Latest Earnings Date 02/23/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9600 unch
on 02/21/24
5.0000 -80.80%
on 01/30/24
-0.9440 (-49.58%)
since 01/19/24
3-Month
0.9600 unch
on 02/21/24
8.1788 -88.26%
on 12/04/23
-6.0372 (-86.28%)
since 11/21/23
52-Week
0.9600 unch
on 02/21/24
150.0240 -99.36%
on 02/22/23
-152.3400 (-99.37%)
since 02/21/23

Most Recent Stories

More News
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0270 (-15.63%)
GRI : 0.9600 (-1.03%)
MBRX : 0.5012 (+0.28%)
XBIO : 3.78 (-1.91%)
AREC : 1.3100 (-7.09%)
CNSP : 0.2863 (-1.28%)
NVNO : 5.32 (-3.62%)
PALI : 0.4290 (-2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

GRI Bio Inc. is a clinical stage biopharmaceutical company which focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio Inc., formerly known as Vallon Pharmaceuticals Inc., is based in PHILADELPHIA, PA.

See More

Key Turning Points

3rd Resistance Point 1.0100
2nd Resistance Point 1.0000
1st Resistance Point 0.9800
Last Price 0.9600
1st Support Level 0.9500
2nd Support Level 0.9400
3rd Support Level 0.9200

See More

52-Week High 150.0240
Fibonacci 61.8% 93.0816
Fibonacci 50% 75.4920
Fibonacci 38.2% 57.9024
Last Price 0.9600
52-Week Low 0.9600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar